Rimsev 800
Rimsev 800: Essential Phosphate Control for Dialysis Patients
Rimsev 800 Tablet, containing Sevelamer Carbonate 800mg, is a specialized prescription medication engineered to effectively manage elevated phosphate levels in the blood (hyperphosphatemia). It is an essential component of treatment for patients undergoing dialysis due to severe chronic kidney disease (CKD). As a potent phosphate binder, Rimsev 800 acts by preventing the absorption of dietary phosphate from the intestine, thereby lowering blood phosphate levels and helping to prevent complications such as hypocalcemia (low calcium levels) often caused by high phosphorus.
How Rimsev 800 Works: When taken with meals, Sevelamer Carbonate in Rimsev 800 binds to phosphate present in the food within the digestive tract. This forms an insoluble complex that is then safely excreted from the body. This targeted mechanism ensures that excess phosphate does not enter the bloodstream, which is vital for maintaining a healthy mineral balance in individuals with compromised kidney function.
Key Benefits of Rimsev 800 Tablet:
- Effective Phosphate Binding with No Absorption: Provides powerful binding of dietary phosphate within the gut, with the active ingredient itself remaining unabsorbed into the bloodstream, thereby minimizing systemic effects.
- Improves Serum Bicarbonate Levels: Helps to stabilize serum bicarbonate levels, playing a crucial role in preventing and managing metabolic acidosis, a common issue in CKD patients.
- Reduces Vascular Calcification Risk: Significantly lowers the chances of vascular calcification and coronary artery calcification, which are critical for protecting cardiovascular health in patients with CKD.
- Comprehensive Biomarker Reduction: Beyond phosphate, it also helps reduce levels of serum cholesterol, uric acid, FGF23 (Fibroblast Growth Factor 23), and HbA1c (Glycated Hemoglobin), offering broad metabolic advantages.
- High Responder Rate in Indian Patients: Demonstrates a high responder rate of more than 70% in Indian patients, highlighting its proven efficacy and relevance in the local demographic.
Rimsev 800 Tablet from Evervital Lifesciences offers essential and multifaceted support for patients on dialysis, providing effective phosphate control and contributing to improved overall health outcomes in the management of chronic kidney disease.
- Description
Description
Rimsev 800: Essential Phosphate Control for Dialysis Patients
Rimsev 800 Tablet, containing Sevelamer Carbonate 800mg, is a specialized prescription medication engineered to effectively manage elevated phosphate levels in the blood (hyperphosphatemia). It is an essential component of treatment for patients undergoing dialysis due to severe chronic kidney disease (CKD). As a potent phosphate binder, Rimsev 800 acts by preventing the absorption of dietary phosphate from the intestine, thereby lowering blood phosphate levels and helping to prevent complications such as hypocalcemia (low calcium levels) often caused by high phosphorus.
How Rimsev 800 Works: When taken with meals, Sevelamer Carbonate in Rimsev 800 binds to phosphate present in the food within the digestive tract. This forms an insoluble complex that is then safely excreted from the body. This targeted mechanism ensures that excess phosphate does not enter the bloodstream, which is vital for maintaining a healthy mineral balance in individuals with compromised kidney function.
Key Benefits of Rimsev 800 Tablet:
- Effective Phosphate Binding with No Absorption: Provides powerful binding of dietary phosphate within the gut, with the active ingredient itself remaining unabsorbed into the bloodstream, thereby minimizing systemic effects.
- Improves Serum Bicarbonate Levels: Helps to stabilize serum bicarbonate levels, playing a crucial role in preventing and managing metabolic acidosis, a common issue in CKD patients.
- Reduces Vascular Calcification Risk: Significantly lowers the chances of vascular calcification and coronary artery calcification, which are critical for protecting cardiovascular health in patients with CKD.
- Comprehensive Biomarker Reduction: Beyond phosphate, it also helps reduce levels of serum cholesterol, uric acid, FGF23 (Fibroblast Growth Factor 23), and HbA1c (Glycated Hemoglobin), offering broad metabolic advantages.
- High Responder Rate in Indian Patients: Demonstrates a high responder rate of more than 70% in Indian patients, highlighting its proven efficacy and relevance in the local demographic.
Rimsev 800 Tablet from Evervital Lifesciences offers essential and multifaceted support for patients on dialysis, providing effective phosphate control and contributing to improved overall health outcomes in the management of chronic kidney disease.
